Jul 21, 2016

F. Hoffmann-La Roche Announces Half Year Results 2016

Name of listed company: Chugai Pharmaceutical Co., Ltd.
Code number: 4519 (1st Section of Tokyo Stock Exchange)
Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
Chairman & CEO: Osamu Nagayama
Inquiries to: Masahiko Uchida,
General Manager, Corporate Communications Dept.

F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its half year results 2016 (January 1 – June 30, 2016).
Roche owns 59.89% of Chugai's outstanding shares (61.37% of the total number of shares issued excluding treasury stock) as of end of June 2016.
The press release and presentation materials can be found on its website (http://www.roche.com).
Chugai’s performance for the period of January 1 to June 30, 2016 is included in the announced Roche Group’s results.

Media Releases Investor Updates Presentation Half-Year Report 2016
  • Like
  • Post
  • LINE it!
  • E-mail
Back to top